|
|
Volumn 29, Issue 6, 2011, Pages 1497-1499
|
|
VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption
|
|
Author keywords
Atherosclerosis; Embolism; Sunitinib; Tyrosine kinase inhibitors; VEGF A
|
|
Indexed keywords
SUNITINIB;
TEMSIROLIMUS;
VASCULOTROPIN;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
PYRROLE DERIVATIVE;
VASCULOTROPIN A;
ABDOMINAL PAIN;
AGED;
AORTA ATHEROSCLEROSIS;
ARTICLE;
ATHEROSCLEROTIC PLAQUE;
CANCER CHEMOTHERAPY;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DIARRHEA;
DISEASE ASSOCIATION;
DISEASE PREDISPOSITION;
DRUG SAFETY;
HUMAN;
INTESTINE INFARCTION;
KIDNEY CARCINOMA;
LAPAROTOMY;
MALE;
METASTASIS;
OUTCOME ASSESSMENT;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RISK FACTOR;
SUPERIOR MESENTERIC ARTERY OBSTRUCTION;
TREATMENT DURATION;
TREATMENT RESPONSE;
DRUG ANTAGONISM;
INFARCTION;
INTESTINE;
PATHOLOGY;
PATHOPHYSIOLOGY;
THROMBOEMBOLISM;
VASCULARIZATION;
AGED;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
HUMANS;
INDOLES;
INFARCTION;
INTESTINES;
MALE;
PLAQUE, ATHEROSCLEROTIC;
PYRROLES;
RISK FACTORS;
THROMBOEMBOLISM;
TOMOGRAPHY, X-RAY COMPUTED;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 84855515664
PISSN: 01676997
EISSN: 15730646
Source Type: Journal
DOI: 10.1007/s10637-010-9500-9 Document Type: Article |
|
Times cited : (19)
|
|
References (6)
|
